Unleashing Innovation: The Business Case for New Approach Methods (NAMs)
By Zachary Liebowitz | January 23rd, 2025
“As we stand on the cusp of a new era in science and industry, the case for NAMs is clear. They are more than a set of tools—they represent a paradigm shift that aligns innovation with ethical responsibility and economic growth.“
Revolutionizing Healthcare: How Induced Pluripotent Stem Cells are Paving the Way for Personalized Medicine
By Zachary Liebowitz | May 30th, 2024
“Not only is this model of personalized medicine more clinically relevant than today’s approaches, it is simultaneously more humane, time effective, and cost efficient.”